English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/1413
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma

AuthorsLázcoz, Paula; Muñoz, Jorge; Nistal, Manuel; Pestaña, Ángel ; Encío, Ignacio; Castresana, Javier S.
Issue Date25-Oct-2006
PublisherBioMed Central
CitationBMC Cancer 2006, 6: 254 (2006)
Abstract[Background] Epigenetic alterations and loss of heterozygosity are mechanisms of tumor suppressor gene inactivation. A new carcinogenic pathway, targeting the RAS effectors has recently been documented. RASSF1A, on 3p21.3, and NORE1A, on 1q32.1, are among the most important, representative RAS effectors.
[Methods] We screened the 3p21 locus for the loss of heterozygosity and the hypermethylation status of RASSF1A, NORE1A and BLU (the latter located at 3p21.3) in 41 neuroblastic tumors. The statistical relationship of these data was correlated with CASP8 hypermethylation. The expression levels of these genes, in cell lines, were analyzed by RT-PCR.
[Results] Loss of heterozygosity and microsatellite instability at 3p21 were detected in 14% of the analyzed tumors. Methylation was different for tumors and cell lines (tumors: 83% in RASSF1A, 3% in NORE1A, 8% in BLU and 60% in CASP8; cell lines: 100% in RASSF1A, 50% in NORE1A, 66% in BLU and 92% in CASP8). In cell lines, a correlation with lack of expression was evident for RASSF1A, but less clear for NORE1A, BLU and CASP8. We could only demonstrate a statistically significant association between hypermethylation of RASSF1A and hypermethylation of CASP8, while no association with MYCN amplification, 1p deletion, and/or aggressive histological pattern of the tumor was demonstrated.
[Conclusion] 1) LOH at 3p21 appears in a small percentage of neuroblastomas, indicating that a candidate tumor suppressor gene of neuroblastic tumors is not located in this region. 2) Promoter hypermethylation of RASSF1A and CASP8 occurs at a high frequency in neuroblastomas.
Publisher version (URL)http://dx.doi.org/10.1186/1471-2407-6-254
URIhttp://hdl.handle.net/10261/1413
DOI10.1186/1471-2407-6-254
ISSN1471-2407
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
1471-2407-6-254.pdf450,41 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.